or
forgot password

    • cancer clinical trials in orange city, FL

    • Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Mid Florida Oncology
    Orange City, Florida 32763
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Mid-Florida Hem Oncology Ctr
    Orange City, Florida 32763
    Non-Small Cell Lung Cancer
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Mid-Florida Hematology & Oncology Centers, PA
    Orange City, Florida 32763
    Neoplasms, Diarrhea
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Mid-Florida Hematology & Oncology Centers, P.A.
    Orange City, Florida 32763
    Lung Cancer, Non-small-cell Lung Carcinoma
    Non-small Cell Lung Cancer Registry
    Mid- Florida Hematology & Oncology Centers, PA
    Orange City, Florida 32763
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Mid-Florida Hematology & Oncology Centers
    Orange City, Florida 32763
    Prostate Cancer
    A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
    Mid Florida Hematology & Oncology
    Orange City, Florida 32763
    Chronic Idiopathic Thrombocytopenic Purpura
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8658
    Orange City, Florida 32763
    Prostate Cancer